| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.075 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.2 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.2 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |